|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.165 USD | +5.71% |
|
+11.78% | -46.28% |
| 06-03 | Verastem Oncology Gets FDA Fast Track Designation for Lung Cancer Drug | DJ |
| 06-03 | Verastem's Lung Cancer Drug Gets FDA Fast Track Designation | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 4.85 | 6.01 | 6.58 |
| Spread/Res. | -14.50% | -31.00% | -36.98% |
| Spread/Supp. | +14.56% | +14.56% | +11.78% |
| Support | 3.62 | 3.62 | 3.71 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- VSTM Stock
- Charts Verastem, Inc.
Select your edition
All financial news and data tailored to specific country editions
